University of Oxford Awarded the IBD Stress Test QuickFire Challenge

July 11, 2019 -
7 days ago
Other news

file2-4.jpeg

LONDON, ENGLAND July 11, 2019- Johnson & Johnson Innovation – JLABS  announced today that the University of Oxford has been selected as the awardee in the IBD Stress Test QuickFire Challenge. The Challenge was designed with the aim to accelerate healthcare innovation to investigate the response of the human immune and gastrointestinal systems to stressors. 

As the awardee of the IBD Stress Test QuickFire Challenge, the University of Oxford team will receive a total of $50,000 in grant funding to further advance its research and access to mentoring from the Johnson & Johnson Family of Companies global network of experts.

The QuickFire Challenges are managed by Johnson & Johnson Innovation, JLABS, with the aim to address today’s greatest health care challenges. JLABS facilities have incubated more than 420 companies to date, advancing biotech, pharmaceutical, medical device, consumer and health tech programs across all JLABS locations: New York City; San Diego; San Francisco; South San Francisco; Boston; Lowell, MA; Houston; Toronto; Beerse, Belgium; Shanghai opening in 2019; and Washington, D.C. opening in 2020.

For more information about the QuickFire Challenges, please visit: https://jlabs.jnjinnovation.com/quickfire-challenges. 

About Johnson & Johnson Innovation 

Johnson & Johnson Innovation, LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers; Johnson & Johnson Innovation – JLABS; Johnson & Johnson Innovation – JJDC, Inc.; and our business development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources needed to help life science startups thrive, all with no strings attached. A Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. For more information about Johnson & Johnson Innovation, please visit: www.jnjinnovation.com. 

About Johnson & Johnson Innovation - JLABS

Johnson & Johnson Innovation – JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS, we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS also produces campaigns to seek out the best science called QuickFire Challenges. For more information, visit www.jlabs.jnjinnovation.com or follow @JLABS.

 


Related content